Biorep Technologies Achieves Breakthrough in Islet Isolation
Biorep Technologies has achieved a significant milestone with the first successful independent research application of the PRISM system in human pancreatic islet isolation. Conducted by the Scottish National Blood Transfusion Service in partnership with Leiden University Medical Center, this event showcases the effective use of Biorep's next-generation laboratory platform.
Independent Validation of the PRISM System
This recent accomplishment indicates that the PRISM system can consistently yield reproducible results in diverse laboratory settings, which is crucial for the system's acceptance and use on an international scale. Felipe Echeverri, CEO of Biorep Technologies, expressed his excitement about this advancement, stating that it highlights the company’s dedication to enhancing cell isolation techniques using dependable laboratory technologies. He emphasized the role of the PRISM system in establishing a new gold standard for workflows related to islet and other cell isolations.
Critical Need for Advanced Solutions in the Field
The phasing out of traditional cell separators, like the COBE 2991, has led laboratories to seek modern, standardized platforms to continue their islet isolation efforts. The PRISM system addresses this gap by providing an automated, modular laboratory environment that ensures controlled, sterile conditions for reproducible isolations. This automates the complex procedures involved and reduces the requirements for extensive operator involvement, providing an effective solution for research facilities.
Partnerships Enhancing Research Capabilities
Biorep is not alone in this venture; the collaboration with renowned institutions such as LUMC and SNBTS aims to further validate and expand the capabilities of the PRISM system. They plan to conduct an evaluation program up until EPITA 2026, sharing findings and enhancing the collective knowledge about islet isolation techniques.
Building on Previous Research
The initial results from the PRISM system were documented by Doppenberg et al. in the journal Transplantation, showcasing the system's potential effectiveness. This recent development builds on that foundational research, reinforcing claims that advancements in islet isolation technology are among the most impactful seen in over three decades.
About Biorep Technologies and its Innovations
Biorep Technologies, Inc. is headquartered in Miami and stands as a global pioneer in advanced cell and tissue isolation systems, effectively supporting research advancements across fields like diabetes and regenerative medicine. For over thirty years, Biorep has merged engineering brilliance with biological understanding to create solutions that foster scientific innovation worldwide.
The PRISM System
The PRISM system represents a forward-thinking approach to tissue management, including collection, washing, buffer exchanges, and islet purification. Originally designed at Leiden University Medical Center, Biorep has further refined the system to enhance its manufacturability and applicability in large-scale settings. It simplifies the entire process of pancreatic islet isolation, with other protocols for hepatocyte applications also under development.
Frequently Asked Questions
What is the significance of the PRISM system?
The PRISM system signifies a breakthrough in islet isolation technology, enhancing the reproducibility and reliability of the process across various laboratories.
Who partnered with Biorep Technologies for this research?
Biorep collaborated with the Scottish National Blood Transfusion Service and Leiden University Medical Center for the independent evaluation of the PRISM system.
Why are advanced isolation systems necessary?
With the discontinuation of older cell separation technologies, there's a pressing need for reliable and modern systems like the PRISM system to continue effective research efforts.
What are the applications of the PRISM system?
The PRISM system is designed primarily for pancreatic islet isolation but is expanding to serve other cell isolation applications as well.
How long has Biorep been in operation?
Biorep Technologies has been operating for over thirty years, establishing itself as a leader in the field of cell and tissue isolation technologies.
